| # | Company | Symbol | Weight | Price | Chg | % Chg |
|---|---|---|---|---|---|---|
| 1 | Tempus Ai Inc | TEM | 9.56% | 74.90 |
-0.01 | (-0.01%) |
| 2 | Crispr Therapeutics Ag | CRSP | 8.58% | 57.72 |
1.73 | (3.09%) |
| 3 | Personalis Inc | PSNL | 6.22% | 10.21 |
0.04 | (0.34%) |
| 4 | Guardant Health Inc | GH | 5.73% | 107.79 |
1.83 | (1.73%) |
| 5 | Twist Bioscience Corp | TWST | 5.36% | 32.46 |
1.29 | (4.14%) |
| 6 | Beam Therapeutics Inc | BEAM | 4.64% | 28.33 |
1.59 | (5.95%) |
| 7 | Natera Inc | NTRA | 4.58% | 241.92 |
3.71 | (1.56%) |
| 8 | 10x Genomics Inc-Class A | TXG | 4.55% | 17.74 |
-0.13 | (-0.75%) |
| 9 | Recursion Pharmaceuticals-A | RXRX | 4.21% | 4.76 |
0.09 | (2.04%) |
| 10 | Veracyte Inc | VCYT | 4.06% | 46.66 |
-1.09 | (-2.28%) |
| 11 | Illumina Inc | ILMN | 4.03% | 127.77 |
-0.19 | (-0.14%) |
| 12 | Adaptive Biotechnologies | ADPT | 3.52% | 16.28 |
-0.85 | (-4.96%) |
| 13 | Ionis Pharmaceuticals Inc | IONS | 3.14% | 81.64 |
-0.20 | (-0.24%) |
| 14 | Caredx Inc | CDNA | 3.11% | 19.17 |
0.31 | (1.67%) |
| 15 | Absci Corp | ABSI | 3.07% | 3.68 |
0.39 | (11.85%) |
| 16 | Schrodinger Inc | SDGR | 2.62% | 17.85 |
0.11 | (0.62%) |
| 17 | Intellia Therapeutics Inc | NTLA | 2.28% | 9.50 |
0.44 | (4.81%) |
| 18 | Pacific Biosciences of Calif | PACB | 2.06% | 2.49 |
0.06 | (2.51%) |
| 19 | Nurix Therapeutics Inc | NRIX | 1.99% | 18.23 |
1.40 | (8.31%) |
| 20 | Genedx Holdings Corp | WGS | 1.77% | 160.86 |
0.49 | (0.30%) |
| 21 | Butterfly Network Inc | BFLY | 1.43% | 3.03 |
0.05 | (1.85%) |
| 22 | Prime Medicine Inc | PRME | 1.40% | 3.82 |
0.21 | (5.82%) |
| 23 | Arcturus Therapeutics Holdin | ARCT | 1.25% | 0.00 |
0.00 | (0.00%) |
| 24 | Amgen Inc | AMGN | 1.21% | 338.13 |
-7.29 | (-2.11%) |
| 25 | Goldman Fs Trsy Oblig Inst 468 | 1.21% | 0.00 |
0.00 | (0.00%) | |
| 26 | Incyte Corp | INCY | 1.07% | 99.00 |
-2.50 | (-2.47%) |
| 27 | Atai Beckley Nv | ATAI | 1.04% | 4.36 |
0.30 | (7.39%) |
| 28 | Cerus Corp | CERS | 1.03% | 2.06 |
0.07 | (3.27%) |
| 29 | 908 Devices Inc | MASS | 0.95% | 6.47 |
0.25 | (3.94%) |
| 30 | Vertex Pharmaceuticals Inc | VRTX | 0.93% | 459.92 |
-3.21 | (-0.69%) |
| 31 | Compass Pathways Plc | CMPS | 0.85% | 5.64 |
0.55 | (10.84%) |
| 32 | Veeva Systems Inc-Class A | VEEV | 0.77% | 240.37 |
-0.97 | (-0.40%) |
| 33 | Quantum-Si Inc | QSI | 0.74% | 1.46 |
0.09 | (6.99%) |
| 34 | Caris Life Sciences Inc | CAI | 0.71% | 27.54 |
0.30 | (1.10%) |
| 35 | Standard Biotools Inc | LAB | 0.34% | 1.48 |
0.04 | (2.43%) |
| ARKK | 82.02 |
1.27 | (1.58%) |
| ARKQ | 114.69 |
2.33 | (2.07%) |
| ARKW | 156.04 |
2.03 | (1.32%) |
| ARKG | 31.37 |
0.54 | (1.76%) |
| ARKF | 50.22 |
0.02 | (0.03%) |
| ARKX | 28.49 |
0.67 | (2.40%) |
| PRNT | 22.61 |
0.21 | (0.94%) |
| IZRL | 29.69 |
-0.02 | (-0.05%) |
The holdings for the ARK Genomic Revolution ETF are updated after each trading day. Exact holdings and weights are subject to change daily. There are currently 35 holdings in the fund.
Data as of 12/04/2025.